CHEK2 and breast carcinoma: The OR that we observed for T+SJVs is numerically somewhat higher than that reported in the 2004 CHEK2 Breast Cancer Case-Control Consortium study of c.1100delC [50], but not significantly, as our 95% CIs do include the point estimate from that study.